EXHIBIT 99.1

 

JOINT FILING AGREEMENT

 

The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the Common Stock of Cabaletta Bio, Inc., a Delaware corporation, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, as amended, on behalf of each of the undersigned.

 

This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.

 

Dated this 1st day of November, 2021.

 

CITADEL SECURITIES LLC

 

CITADEL ADVISORS LLC

 

 
By: /s/ Guy Miller   By: /s/ Gregory Johnson  
  Guy Miller, Authorized Signatory     Gregory Johnson, Authorized Signatory  
           
       

CITADEL SECURITIES GROUP LP

 

CITADEL ADVISORS HOLDINGS LP

 

 
By: /s/ Guy Miller   By: /s/ Gregory Johnson  
  Guy Miller, Authorized Signatory     Gregory Johnson, Authorized Signatory  
           
       

CITADEL SECURITIES GP LLC

 

 

CITADEL GP LLC

 

 
By: /s/ Guy Miller   By: /s/ Gregory Johnson  
  Guy Miller, Authorized Signatory     Gregory Johnson, Authorized Signatory  
           
       
   

KENNETH GRIFFIN

 

 
    By: /s/ Gregory Johnson  
      Gregory Johnson, attorney-in-fact*  

 

 

 
*Gregory Johnson is signing on behalf of Kenneth Griffin as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein.  The power of attorney was filed as an attachment to a filing by Citadel Advisors LLC on Schedule 13G for Jaws Acquisitions Corp. on February 1, 2021.